Bette Korber

Los Alamos National Laboratory — United States

Immunology and Microbiology · Life Sciences

130h-index58.7kcitations515works5.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(389), HIV/AIDS drug development and treatment(118), Immune Cell Function and Interaction(114), vaccines and immunoinformatics approaches(102), HIV/AIDS Research and Interventions(75)

Publications515 total

Identification and genomic characterisation of BA.3.2: a highly divergent BA.3-related SARS-CoV-2 lineage from southern Africa
2025· 1 citedOpen Access
Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potential
2025Open Access
SARS-CoV-2 variants: biology, pathogenicity, immunity and control
Nature Reviews Microbiology·2025· 8 cited
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans
Cell·2025Open Access
Real-time monitoring of SARS-CoV-2 evolution during the COVID-19 pandemic
Cell Host & Microbe·2025· 1 cited
Consistent Induction of Broadly Neutralizing HIV Antibodies by a Novel Two-Step Mechanism Informs Immunogen Design
2025· 1 citedOpen Access
Vaccine Elicitation of HIV-1 Neutralizing Antibodies Against Both V2 Apex and Fusion Peptide in Rhesus Macaques
2025Open Access
Bayesian estimation of HIV acquisition dates for prevention trials
mBio·2025· 2 citedOpen Access
Corrigendum to ‘Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study’. EBioMedicine 2024;108: 105320
EBioMedicine·2025Open Access
A systematic nomenclature for mpox viruses causing outbreaks with sustained human-to-human transmission
Nature Medicine·2025· 5 citedOpen Access
Transient glycan shield reduction induces CD4-binding site broadly neutralizing antibodies in SHIV-infected macaques
Cell Reports·2025· 1 citedOpen Access
A conserved region T-cell vaccine for Sarbecoviruses
2025Open Access
A comprehensive engineering strategy improves potency and manufacturability of a near pan-neutralizing antibody against HIV
Structure·2025· 2 citedOpen Access
Env-antibody coevolution identifies B cell priming as the principal bottleneck to HIV-1 V2 apex broadly neutralizing antibody development
2025· 8 citedOpen Access
Computationally Selected Multivalent HIV-1 Subtype C Vaccine Protects Against Heterologous SHIV Challenge
Vaccines·2025· 2 citedOpen Access
A Pentavalent HIV-1 Subtype C Vaccine Containing Computationally Selected gp120 Strains Improves the Breadth of V1V2 Region Responses
Vaccines·2025· 3 citedOpen Access
Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadth
EBioMedicine·2025· 5 citedOpen Access
Transient glycan-shield reduction induces CD4-binding site broadly neutralizing antibodies in SHIV-infected macaques
2024Open Access
Computationally Selected Multivalent HIV-1 Subtype C Vaccine Protects Against Heterologous SHIV Challenge
Preprints.org·2024Open Access
Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial
The Lancet HIV·2024· 7 citedOpen Access
page 1 of 26Next →

Frequent Co-authors

Beatrice H. Hahn(17), Barton F. Haynes(14), Tanmoy Bhattacharya(12), David C. Montefiori(12), George M. Shaw(10), Elena Giorgi(9), Feng Gao(9), Peter Hraber(9), John R. Mascola(8), James Theiler(7), Brian Foley(7), Steven M. Wolinsky(7), Brandon F. Keele(6), Jesus F. Salazar-Gonzalez(6), S. Gnanakaran(5), Julie M. Decker(5), Maria G. Salazar(5), Myron S. Cohen(5), Alan S. Perelson(5), Michael S. Seaman(5)